Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Shivaswamy V et al. |
Tacrolimus and sirolimus induce reproductive abnormalities in female rats. |
2011 |
Transplantation |
pmid:21508897
|
Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Rosen HR et al. |
Significance of early aminotransferase elevation after liver transplantation. |
1998 |
Transplantation |
pmid:9448146
|
McCune TR et al. |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. |
1998 |
Transplantation |
pmid:9448150
|
Connor A et al. |
Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure. |
2012 |
Transplantation |
pmid:23318306
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Plock JA et al. |
Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. |
2015 |
Transplantation |
pmid:26102613
|
Stevens RB et al. |
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. |
2008 |
Transplantation |
pmid:18497677
|
Gurk-Turner C et al. |
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. |
2008 |
Transplantation |
pmid:18497682
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Rush DN et al. |
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. |
2009 |
Transplantation |
pmid:19935461
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Arns W et al. |
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial. |
2017 |
Transplantation |
pmid:28658202
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Taber DJ et al. |
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. |
2017 |
Transplantation |
pmid:28658199
|
Diémé B et al. |
Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling. |
2014 |
Transplantation |
pmid:24598938
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Ashokkumar C et al. |
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. |
2011 |
Transplantation |
pmid:21747326
|
Cosio FG et al. |
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. |
2007 |
Transplantation |
pmid:17318073
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Gupta A et al. |
Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin. |
2009 |
Transplantation |
pmid:19696644
|
Casey MJ et al. |
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. |
2014 |
Transplantation |
pmid:24717218
|
Stifft F et al. |
Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation. |
2014 |
Transplantation |
pmid:24686426
|
Shibutani S et al. |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. |
2005 |
Transplantation |
pmid:15849542
|
Peloso LJ et al. |
The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. |
2014 |
Transplantation |
pmid:25221905
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Ciancio G et al. |
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. |
2002 |
Transplantation |
pmid:11965039
|
Alhamad T et al. |
Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy. |
2017 |
Transplantation |
pmid:28422926
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Robertsen I et al. |
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. |
2015 |
Transplantation |
pmid:25148382
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
van Rijen MM et al. |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. |
2002 |
Transplantation |
pmid:12042657
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Paramesh AS et al. |
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. |
2004 |
Transplantation |
pmid:14724447
|
Boillot O et al. |
Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study. |
1998 |
Transplantation |
pmid:9825815
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Jain AB et al. |
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. |
1998 |
Transplantation |
pmid:9825817
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Zhao W et al. |
Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. |
2012 |
Transplantation |
pmid:22450597
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Jacobson PA et al. |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. |
2012 |
Transplantation |
pmid:22334041
|
Schneeberger S et al. |
Cytomegalovirus-related complications in human hand transplantation. |
2005 |
Transplantation |
pmid:16123716
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Ciancio G et al. |
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. |
2005 |
Transplantation |
pmid:16123718
|
Vossen M et al. |
Bone quality in swine composite tissue allografts: effects of combination immunotherapy. |
2005 |
Transplantation |
pmid:16123723
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Poncelet AJ et al. |
Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus. |
2008 |
Transplantation |
pmid:19077894
|
Uchida N et al. |
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. |
2011 |
Transplantation |
pmid:21677598
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Macedo C et al. |
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. |
2012 |
Transplantation |
pmid:22343334
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Wu MJ et al. |
Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients. |
2011 |
Transplantation |
pmid:21912349
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Aw MM et al. |
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. |
2003 |
Transplantation |
pmid:12660504
|
Charpentier B et al. |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. |
2003 |
Transplantation |
pmid:12660513
|
Jain A et al. |
One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. |
2011 |
Transplantation |
pmid:21378604
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Gruessner RW et al. |
Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. |
2004 |
Transplantation |
pmid:15239611
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Baggio B et al. |
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. |
2005 |
Transplantation |
pmid:16314806
|
Margreiter R et al. |
A double-hand transplant can be worth the effort! |
2002 |
Transplantation |
pmid:12134104
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|